Purchase Order 75F40121P00422
Award Date
8/11/21
Potential Completion Date
11/8/21
Potential Value
$95K
Federal Agency
Food and Drug Administration
Awardee
Olink Proteomics AB
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
B529 - Special Studies/Analysis- Scientific Data
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
East Watertown, MA 02472, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $79,345.00 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The contract is for quantitative proteomics measurement of human COVID-19 plasma samples, which supports the FDA's research efforts related to the COVID-19 pandemic. Olink Proteomics specializes in protein biomarker discovery and has provided a range of proteomics instruments, reagents, and analysis services to various...
This contract was awarded by the Department of Health and Human Services Food and Drug Administration to Olink Proteomics AB, a foreign-owned for-profit company, to provide proteomics analysis of plasma samples. The award, valued at $157,028.00, is a Firm Fixed Price purchase order with an August 2020 completion date. Olink Proteomics specializes in multiplex protein biomarker analysis technologies and has provided similar services to agencies like the National Institutes of Health and...
The Department of Health and Human Services (HHS) Food and Drug Administration (FDA) awarded a firm-fixed price purchase order contract to Olink Proteomics Inc. for $115,920.00 to provide protein biomarker analysis of cardiotoxicity in human plasma samples. The contract has a completion date of December 31, 2022 and was awarded on June 9, 2022. No set-aside designation was used for this award. Olink Proteomics is a biotechnology company that specializes in proteomics solutions and has held...
This is a $147,501.31 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Olink Proteomics Inc., a foreign-owned, for-profit biotechnology company. The contract, which has no set-aside designation, is for the acquisition of Olink's O-Link System and reagents. Olink Proteomics specializes in protein biomarker discovery solutions and has provided a variety of proteomics instruments, assay kits, and analysis services to support government research efforts,...
The Department of Health and Human Services Food and Drug Administration awarded a $87,620 purchase order to Olink Proteomics Inc. of Waltham, Massachusetts. The firm fixed price contract is for quantitative proteomics measurement of 100 human COVID-19 plasma samples. Performance will take place in Waltham from July 18, 2023 through December 8, 2023. The solicitation sought quantitative proteomics measurement of the specified plasma samples, as described in the attached combined synopsis and...
This firm fixed-price purchase order was awarded by the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute to Olink Proteomics AB, a foreign-owned for-profit organization, to provide Olink Biomarker Analysis Services. The $249,250.00 contract has a performance period through May 16, 2024 and does not have a set-aside designation. Olink Proteomics specializes in multiplex protein biomarker analysis platforms and has previously supported NIH, Food and Drug...
This is a $30,625.00 firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute on Aging to Olink Proteomics Inc., a foreign-owned for-profit biotechnology company. The contract is for Olink's EXPLORE HT proteomics analysis service, which provides high-multiplex protein biomarker discovery capabilities. Olink Proteomics has a history of providing proteomics instruments, reagents, and analysis services to...
The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a firm fixed-price purchase order to Olink Proteomics AB, a foreign-owned for-profit organization based in Sweden, to provide 200 samples of Olink Explore 3072 protein analysis services for $140,000. The services will be performed in Watertown, Massachusetts. This award was made under a simplified acquisition without any set-aside, and the original solicitation...
The Department of Health and Human Services, National Institutes of Health, National Human Genome Research Institute awarded a firm fixed price purchase order contract to Olink Proteomics AB, a foreign-owned for-profit organization, to evaluate multiple proteins in plasma samples. The $247,996.10 contract has a performance period ending on May 13, 2023. No set-aside designation was used for this award. Olink Proteomics AB specializes in proprietary multiplex protein biomarker analysis...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a $249,250.00 firm fixed price purchase order to Olink Proteomics AB, a foreign-owned for-profit organization, for biomarker analysis services. The services include the use of Olink's proprietary multiplex protein biomarker analysis platforms and technologies to support biomedical research efforts across disease areas like cancer, cardiovascular disease, and COVID-19. The...